Literature DB >> 8046683

Feline spinal lymphosarcoma: a retrospective evaluation of 23 cats.

S B Lane1, J N Kornegay, J R Duncan, J E Oliver.   

Abstract

A retrospective study of pathologically confirmed cases of feline spinal lymphosarcoma (FSL) admitted to the Colleges of Veterinary Medicine at the University of Georgia and North Carolina State University from 1973 to 1988 was conducted. Two hundred fourteen cases of feline lymphosarcoma were diagnosed histopathologically; involvement of the central nervous system (CNS) was identified in 26 (12.1%). Twenty-three of these tumors involved the spinal cord, and 22 of the 23 were solitary. A predilection for the thoracic and lumbar vertebral canal was noted. Most cats with spinal disease were young, with mean and median ages of 43 and 24 months, respectively; 67 cats were 36 months of age or younger. In most cases, affected cats had acute neurological deterioration after an initial insidious course. Extraneural abnormalities were not consistently present. Neoplastic lymphocytes diagnostic of FSL were identified on cerebrospinal fluid (CSF) analysis in 6 of 17 cats evaluated. Sixteen of 17 cats evaluated had serologically positive test results for feline leukemia virus (FeLV) p27 antigen, and all cats tested for feline immunodeficiency virus (FIV) antibodies had negative test results.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046683     DOI: 10.1111/j.1939-1676.1994.tb03205.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  10 in total

1.  Primary cerebral T-cell lymphoma in a sea otter (enhydra lutris).

Authors:  Natsuki Tanaka; Takeshi Izawa; Emi Kashiwagi-Yamamoto; Mitsuru Kuwamura; Miki Ozaki; Tatsuko Nakao; Jyoji Yamate
Journal:  J Vet Med Sci       Date:  2013-08-13       Impact factor: 1.267

2.  Apocrine gland anal sac adenocarcinoma with perineural metastasis in a cat.

Authors:  Joseph S Raleigh; Matthew R Lanza; James A Perry
Journal:  JFMS Open Rep       Date:  2018-12-03

3.  Neurolymphomatosis caused by T-cell lymphosarcoma in a cat: imaging description and treatment review.

Authors:  Michaela J Beasley; Elizabeth C Hiebert; Danielle N Daw; Kayla J Alexander; Jennifer M Gambino
Journal:  JFMS Open Rep       Date:  2019-02-25

Review 4.  Feline spinal cord diseases.

Authors:  Katia Marioni-Henry
Journal:  Vet Clin North Am Small Anim Pract       Date:  2010-09       Impact factor: 2.093

5.  Effectiveness and Adverse Events of Cyclophosphamide, Vincristine, and Prednisolone Chemotherapy in Feline Mediastinal Lymphoma Naturally Infected with Feline Leukemia Virus.

Authors:  Supita Sunpongsri; Attawit Kovitvadhi; Jatuporn Rattanasrisomporn; Viphavee Trisaksri; Nichakorn Jensirisak; Tassanee Jaroensong
Journal:  Animals (Basel)       Date:  2022-03-31       Impact factor: 2.752

6.  Feline lymphoma of the nervous system. Immunophenotype and anatomical patterns in 24 cases.

Authors:  Maria Teresa Mandara; Alessia Domini; Giuseppe Giglia
Journal:  Front Vet Sci       Date:  2022-09-08

Review 7.  The paralyzed cat. Neuroanatomic diagnosis and specific spinal cord diseases.

Authors:  Arianna Negrin; Scott Schatzberg; Simon R Platt
Journal:  J Feline Med Surg       Date:  2009-05       Impact factor: 2.015

8.  Clinical and magnetic resonance imaging findings in 92 cats with clinical signs of spinal cord disease.

Authors:  Rita Gonçalves; Simon R Platt; Francisco J Llabrés-Díaz; Katherine H Rogers; Alberta de Stefani; Lara A Matiasek; Vicki J Adams
Journal:  J Feline Med Surg       Date:  2008-07-03       Impact factor: 2.015

Review 9.  The wobbly cat. Diagnostic and therapeutic approach to generalised ataxia.

Authors:  Jacques Penderis
Journal:  J Feline Med Surg       Date:  2009-05       Impact factor: 2.015

10.  Clinical and magnetic resonance imaging features of lymphoma involving the nervous system in cats.

Authors:  Alexane Durand; Erin Keenihan; Daniela Schweizer; Arianna Maiolini; Julien Guevar; Anna Oevermann; Rodrigo Gutierrez-Quintana
Journal:  J Vet Intern Med       Date:  2022-01-20       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.